口腔疾病,包括龋齿和牙周炎,是世界上最普遍的疾病之一,是微生物菌群失调的结果。几种细菌菌株正在被测试为潜在的口腔健康促进生物,但通常它们是从生态位分离的物种,而不是它们必须发挥其益生菌作用的地方,通常来自粪便样本。我们假设与健康状况相关的口腔居民将比传统的更有效,肠道相关的益生菌物种在关键方面,如疾病发生的口腔部位的定植或拥有口腔健康促进功能,以及安全性和毒性等更实际的问题,并建立适当的给药剂量。作为这些活跃的殖民者的一个例子,我们描述了牙本质链球菌的病例,从无龋齿个体的牙菌斑中分离出的一种新的链球菌。我们已经在98%的健康个体的牙菌斑样本中检测到它,正如预期的那样,它不产生任何有毒的次级代谢产物,也不能在模拟胃消化中存活,防止潜在的副作用。此外,这个物种有双重益生菌作用,因为它通过产生细菌素抑制主要口腔病原体的生长,并且还通过精氨酸溶解途径缓冲酸性pH(龋齿的主要原因)。我们建议使用牙本质菌作为一种有前途的抗蛀牙益生菌。
Oral diseases, including dental caries and periodontitis, are among the most prevalent diseases worldwide and develop as a consequence of a microbial dysbiosis. Several bacterial strains are being tested as potential oral health-promoting organisms, but usually they are species isolated from niches other than the site where they must exert its probiotic action, typically from fecal samples. We hypothesize that oral inhabitants associated to health conditions will be more effective than traditional, gut-associated probiotic species in key aspects such as colonization of the oral site where disease takes place or the possession of oral health promoting functions, as well as more practical issues like safety and toxicity, and establishing proper doses for administration. As an example of these active colonizers, we describe the
case of Streptococcus dentisani, a new streptococcal species isolated from dental plaque of caries-free individuals. We have detected it in 98% of dental plaque samples from healthy individuals and, as expected, it does not produce any toxic secondary metabolite and does not survive a simulated stomach digestion, preventing potential secondary effects. Besides, this species has a double probiotic action, as it inhibits the growth of major oral pathogens through the production of
bacteriocins, and also buffers acidic pH (the primary cause of dental caries) through an arginolytic pathway. We propose the use of S. dentisani as a promising probiotic against tooth decay.